Clinical Trial Update: Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing pemetrexed with gefitinib in locally advanced or metastatic non-small cell lung cancer patients who have previously received platinum …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Iressa (gefitinib)

Snippet

Sponsor: Chinese Society of Lung Cancer | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED